The company's technical setup has turned constructive — golden-cross formation, rising volume accumulation, RSI at 57, three beats in the last four quarters — yet revenue has been contracting approximately 4% year-over-year, the business lacks a competitive moat, and the reward-to-risk ratio is below 1-to-1 at current prices, making the setup unattractive for new buyers even as near-term price momentum improves.
Thesis pillars
- Momentum Breakout Thin Upside→Stable
- Revenue Contraction Challenges Recovery→Stable
- Exceptional Cash Conversion No Moat→Stable
- +1 more pillar — see the Why tab for full reasoning
International Flavors & Fragran (IFF) Stock Analysis
Breakout setup
Basic Materials · Specialty Chemicals
Hold if already holding. Not a fresh buy at $83.83, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (0.7% away).
International Flavors & Fragrances creates and manufactures flavors, food ingredients, enzymes, cultures, and fragrance compounds sold to food, beverage, personal care, and health product manufacturers worldwide. The company reported $10.890 billion in 2025 sales across four... Read more
Hold if already holding. Not a fresh buy at $83.83, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (0.7% away). Chart setup: Golden cross, above all MAs, RSI 70, MACD bullish. Multiple concerning factors. Consider reducing position. | News modifier +1 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Score 4.9/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news boost analyst 0.35, earnings proximity 31d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-07-06Recent Developments — International Flavors & Fragran
Latest news
- NEWS Morgan Stanley Maintains Overweight on Intl Flavors & Fragrances, Raises Price Target to $95 — benzinga Jul 1, 2026 neutral
- NEWS Argus Research Maintains Buy on Intl Flavors & Fragrances, Raises Price Target to $85 — benzinga Jun 30, 2026 positive
- NEWS Citigroup Maintains Buy on Intl Flavors & Fragrances, Lowers Price Target to $88 — benzinga Jun 24, 2026 neutral
- NEWS Benchmark Initiates Coverage On Intl Flavors & Fragrances with Buy Rating, Announces Price Target of $100 — benzinga Jun 9, 2026 neutral
- NEWS IFF Reshapes Portfolio With $4.3 Billion Sale, Targets Higher-Margin Business — benzinga May 29, 2026 positive
Generated 2026-07-06T04:40:27Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Revenue shrinking — -3.6% YoY. Growth thesis broken unless recovery story develops.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $83.83, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (0.7% away). Chart setup: Golden cross, above all MAs, RSI 70, MACD bullish. Multiple concerning factors. Consider reducing position. | News modifier +1 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Target $96.40 (+15.0%), stop $79.39 (−5.6%), A.R:R -0.1:1. Score 4.9/10, moderate confidence.
Take-profit target: $96.40 (+15.0% upside). Target $96.40 (+15.0%), stop $79.39 (−5.6%), A.R:R -0.1:1. Stop-loss: $79.39.
Analyst target reached - limited upside remaining; Near 52-week high (0.7% away); Earnings estimates trending DOWN.
International Flavors & Fragran trades at a P/E of 26.0 (forward 17.4). TrendMatrix value score: 6.0/10. Verdict: Hold.
21 analysts cover IFF with a consensus score of 4.0/5. Average price target: $91.
What does International Flavors & Fragran do?International Flavors & Fragrances creates and manufactures flavors, food ingredients, enzymes, cultures, and fragrance...
International Flavors & Fragrances creates and manufactures flavors, food ingredients, enzymes, cultures, and fragrance compounds sold to food, beverage, personal care, and health product manufacturers worldwide. The company reported $10.890 billion in 2025 sales across four segments after divesting Pharma Solutions in May 2025, with 28% from the U.S. and no single customer exceeding 10% of sales; approximately 21,500 employees operate across 170 facilities in 30 countries.